ArticleJournal for immunotherapy of cancer2019

Anti-PD-1 monoclonal antibody MEDI0680 in a phase I study of patients with advanced solid malignancies.

Aung Naing et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.